Visceral leishmaniasis infection in a patient with psoriasis treated with efalizumab

MeSH terms

• Adult
• Animals
• Antibodies, Monoclonal / administration & dosage*
• Antibodies, Monoclonal / adverse effects*
• Antibodies, Monoclonal, Humanized
• Biological Products / administration & dosage*
• Biological Products / adverse effects*
• Diptera
• Drug Therapy, Combination
• Humans
• Leishmania / immunology
• Leishmaniasis, Visceral / drug therapy
• Leishmaniasis, Visceral / immunology*
• Leishmaniasis, Visceral / pathology
• Male
• Psoriasis / drug therapy*
• Psoriasis / immunology
• Psoriasis / pathology
• Treatment Outcome